Trends in Prices, Market Share, and Spending on Self-administered Disease-Modifying Therapies for Multiple Sclerosis in Medicare Part D-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Trends in Prices, Market Share, and Spending on Self-administered Disease-Modifying Therapies for Multiple Sclerosis in Medicare Part D

Published:2019-11-01 Issue:11 Volume:76 Page:1386
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

San-Juan-Rodriguez Alvaro¹,Good Chester B.²³,Heyman Rock A.⁴⁵,Parekh Natasha²³,Shrank William H.²³,Hernandez Inmaculada¹

Affiliation:

1. Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania

2. Division of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania

3. Center for High-Value Health Care, Insurance Services Division, UPMC Health Plan, Pittsburgh, Pennsylvania

4. Department of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania

5. Multiple Sclerosis Center, UPMC Magee-Womens Hospital, Pittsburgh, Pennsylvania

Publisher

American Medical Association (AMA)

Subject

Clinical Neurology

Link

https://jamanetwork.com/journals/jamaneurology/articlepdf/2748918/jamaneurology_sanjuanrodriguez_2019_br_190003.pdf

Reference9 articles.

1. Economics and cost-effectiveness of multiple sclerosis therapies in the USA.;Hartung;Neurotherapeutics,2017

2. The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?;Hartung;Neurology,2015

3. Utilization, cost trends, and member cost-share for self-injectable multiple sclerosis drugs—pharmacy and medical benefit spending from 2004 through 2007.;Kunze;J Manag Care Pharm,2007

4. Specialty drug spending trends among Medicare and Medicare Advantage enrollees, 2007-11.;Trish;Health Aff (Millwood),2014

5. Trends in coverage for disease-modifying therapies for multiple sclerosis in Medicare part D.;Hartung;Health Aff (Millwood),2019

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Glucagon-Like Peptide-1 Agonists in the Treatment of Multiple Sclerosis: A Narrative Review;Cureus;2024-08-19

2. Healthcare utilization and costs associated with autologous haematopoietic stem cell transplantation in Norwegian patients with relapsing remitting multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-04

3. Economic burden of multiple sclerosis in the United States: A systematic literature review;Journal of Managed Care & Specialty Pharmacy;2023-12

4. Changes In Net Prices And Spending For Pharmaceuticals After The Introduction Of New Therapeutic Competition, 2011–19;Health Affairs;2023-08-01

5. The contribution of fungi to the global economy;Fungal Diversity;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3